新生儿坏死性小肠结肠炎实验室及生化、生物诊断技术的研究进展  

Advances in laboratory,biochemical and biodiagnostic techniques for neonatal necrotizing enterocolitis

作　　者：张慧娟[1] 袁显文[1] 王芳[1] 孙立华[1] ZHANG Hui-juan;YUAN Xian-wen;WANG Fang;SUN Li-hua(Qingdao Eighth People's Hospital,Qingdao,Shandong 266100,China)

机构地区：[1]青岛市第八人民医院,山东青岛266100

出　　处：《青岛医药卫生》2019年第1期43-46,共4页Qingdao Medical Journal

基　　金：青岛市卫生科技计划资助项目(2013-WSzd063)

摘　　要：作为新生儿期常见的危重胃肠道疾病,新生儿坏死性小肠结肠炎(Neonatal necrofizing ente-rocolitis,NEC)发病急,病情进展较快,病死率较高。早期诊断、干预、治疗,持续观察、及时评估患儿病情动态变化对于新生儿的生存及预后至关重要。本文就与NEC诊断相关的实验室及生化、生物标志物技术研究进展进行综述。As a common critical gastrointestinal disease in the neonatal period,neonatal necrofizing enterocolitis(NEC)has an acute onset,rapid progression and high mortality.Early diagnosis,early intervention,treatment,continuous observation,and assessment of the dynamic changes of the child’s condition are crucial for the newborn’s recovery.The article reviews the research progress of NEC diagnostic related laboratories and biochemical and biomarker technologies.

关 键 词：新生儿坏死性小肠结肠炎 实验室 生化 生物 研究进展 

分 类 号：R722.1[医药卫生—儿科]